Tools4Patient Predicts Placebo Response in Osteoarthritis Trials
Tools4Patient recently presented data showing its Placebell predicted placebo response in a Phase II randomized controlled trial (RCT) for osteoarthritis (OA). Placebell is technology using predictive modeling that is proven to reduce the impact of the placebo response in clinical trials under real-world conditions. Data from the Phase II RCT, “Predicting the Placebo Response in OA to Improve the Precision of the Treatment Effect Estimation,” was presented as a late-breaking abstract at the OARSI Connect Virtual World Congress on Osteoarthritis.
The placebo response is a major contributing factor to late-stage clinical trial failures in many therapeutic areas, and Placebell’s predictive method addresses this complex challenge. Placebell combines machine learning-based algorithms with individual patient psychology and personality data to predict the individual placebo response in a patient before the first dose of a drug is administered.
In the study, Tools4Patient applied a Placebell chronic pain model that had been built by meta-analysis that included individual data from 211 placebo-treated patients from several studies conducted by Tools4Patient. The model was pre-specified and used to predict placebo response in all trial patients receiving an intra-articular injection of a novel compound in the sponsored Phase II RCT. Results were compared for five different endpoints in the trial: average pain score, three components of the WOMAC battery focusing on pain, joint stiffness and physical function, and the patient global assessment score.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
